Narrative Nursing for Cesarean Mothers' Anxiety and Breastfeeding Confidence
NARRCARE
Psychological Effects and Breastfeeding Self-Efficacy of a Structured Four-Step Narrative Nursing Intervention in Cesarean Mothers: A Randomized Controlled Mixed-Methods Study
4 other identifiers
interventional
160
1 country
1
Brief Summary
This study tests whether a nurse-led "4-step narrative nursing" program can reduce anxiety and improve breastfeeding confidence in mothers who are having a planned or non-emergency cesarean section. What is the problem? About 30-40% of Chinese cesarean mothers feel high anxiety after surgery, and 1 in 5 is at risk for postpartum depression. Low confidence in breastfeeding is also common. What will we do? We will randomly assign 160 mothers (1:1) to either: Usual care - standard education and ward care, or Usual care plus narrative nursing - four short (10-20 min) conversations with a trained nurse: Before surgery - help the mother talk about her fears. 24-48 h after surgery - encourage her to "name" pain or worries and separate them from herself. Before discharge - guide her to find positive moments and build a "strong-mom" story. Two weeks later by phone - strengthen the new story and review feeding success. What will we measure? Main result: anxiety score at 48 h (STAI scale). Other results: depression risk, breastfeeding confidence, pain, and feeding rates up to 3 months. Possible benefits: Lower anxiety, better mood, higher breastfeeding rates. No drugs or extra procedures are involved, only talking. Risks: Minimal; some mothers may feel emotional during conversations, but nurses can pause or refer to counselling if needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 18, 2025
November 1, 2025
3 months
November 26, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postpartum anxiety at 48 hours
Mean score on the State-Trait Anxiety Inventory (STAI-State, 20 items) assessed 48 hours after cesarean delivery. Lower scores indicate less anxiety.
48 hours post-surgery
Secondary Outcomes (4)
Postpartum depression risk
48 hours, 2 weeks, 3 months postpartum
Breastfeeding self-efficacy
48 hours, 2 weeks, 3 months postpartum
Pain intensity
48 hours and 2 weeks postpartum
Breastfeeding continuation rate
3 months postpartum
Study Arms (2)
Routine perinatal care
NO INTERVENTIONParticipants receive standard ward education, nursing care, discharge instructions, and routine telephone follow-up without any additional narrative sessions.
4-step narrative nursing
EXPERIMENTALParticipants receive usual care plus four nurse-led narrative sessions (pre-op externalization, post-op deconstruction, pre-discharge reconstruction, and 2-week meaning-reconstruction phone call) aimed at reducing anxiety and enhancing breastfeeding confidence.
Interventions
Four nurse-led storytelling sessions (pre-operative externalization, post-operative deconstruction, pre-discharge reconstruction, and 2-week meaning-reconstruction phone call) aimed at reducing anxiety and increasing breastfeeding self-efficacy.
Eligibility Criteria
You may qualify if:
- Women aged 18-50 years
- Scheduled for elective or non-emergency cesarean section at ≥37 weeks
- Able to communicate in Mandarin and provide written informed consent
- Expected hospital stay ≥24 h
- Singleton pregnancy with stable maternal and neonatal condition allowing routine mother-baby contact
You may not qualify if:
- Severe psychiatric disorders (schizophrenia, bipolar disorder, active suicidal ideation)
- Maternal or neonatal need for ICU/NICU admission
- Emergency cesarean section preventing baseline assessment
- Communication or cognitive impairment precluding interview
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xi Huanglead
- Xiamen Universitycollaborator
- Yilong People's Hospitalcollaborator
Study Sites (1)
Yilong County Maternal and Child Health Hospital
Nanchong, Sichuan, 637600, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single-center, two-arm, randomized, parallel-group, superiority trial with blinded outcome assessment.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Master's student
Study Record Dates
First Submitted
November 26, 2025
First Posted
December 9, 2025
Study Start
October 1, 2025
Primary Completion
January 1, 2026
Study Completion
March 1, 2026
Last Updated
December 18, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- IPD and supporting information will be made available beginning 9 months after the primary results paper has been accepted for publication and ending 36 months after that date. An extension may be granted if a justifiable request is received before the closing date.
- Access Criteria
- Access is limited to qualified researchers with IRB/REC-approved, methodologically sound proposals relevant to the approved indication. Only de-identified participant data and the data dictionary will be provided. Requests should be e-mailed to 【corresponding-author@univ.edu】 with a 1-page protocol and statistical analysis plan. A data-sharing agreement outlining terms of use, confidentiality, and no attempt to re-identify participants must be signed before access is granted. Data will be shared through a password-protected secure cloud link; download is logged and audited.
Yes, we plan to share individual participant data (IPD). The de-identified IPD underlying published results will be made available to qualified researchers beginning 9 months after article publication and ending 36 months post-publication. Data access will be granted after approval of a methodologically sound proposal and execution of a data-sharing agreement. Interested parties should contact the corresponding author.